Evidence map›Paper›PMID 31178915›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2019

Denis Zofou, Golda Lum Shu, Josepha Foba-Tendo, Merveille Octavie Tabouguia, Jules-Clement N Assob

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. The Effect ofFoods (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Molecules (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Denis ZofouMedical Research and Applied Biochemistry Laboratory (Drug Discovery and Development Research Unit), University of Buea, Cameroon.ORCID 0000-0002-3421-7609
Golda Lum ShuMedical Research and Applied Biochemistry Laboratory (Drug Discovery and Development Research Unit), University of Buea, Cameroon.
Josepha Foba-TendoDepartment of Chemistry, Faculty of Science, University of Buea, Cameroon.ORCID 0000-0002-1535-4878
Merveille Octavie TabouguiaMedical Research and Applied Biochemistry Laboratory (Drug Discovery and Development Research Unit), University of Buea, Cameroon.
Jules-Clement N AssobMedical Research and Applied Biochemistry Laboratory (Drug Discovery and Development Research Unit), University of Buea, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe threat to human health posed by multidrug-resistant strains of S

methodsPectin was extracted from alcohol extractives-free peel by acidic hydrolysis at a temperature of 80°C for one hour at pH 2 and 4. The pectin was precipitated with 95% alcohol at an extract to alcohol ratio of 1:10 v/v. Antimicrobial activity was determined using agar well diffusion technique. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values were determined using the broth dilution technique. An

resultsOnly one of the extracts (crude pectin pH 2.5) was active against all the

conclusionThe present study highlights the potential of pectin oligosaccharides as new source of anti-Salmonella drugs. Further investigations including exploration of mechanism of action of the most active pectin extracts/hydrolysates are envisaged.

Identifiers

PMID31178915
PMCPMC6507263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.